Laboratory assessment of HLA antibodies circa 2006: making sense of sensitivity

Transplantation Reviews

Volumn 20, Issue 4, 2006, Pages 189-194

  Gebel, Howard M ^a   Bray, Robert A ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY;

ANTIBODY DETECTION; ARTICLE; ASSAY; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FLOW CYTOMETRY; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; HEART GRAFT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; LABORATORY TEST; LYMPHOCYTE; ORGAN DONOR; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

EID: 33751094805     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trre.2006.07.006     Document Type: Note

References (36)

1. Patel R., and Terasaki P.I. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 280 (1969) 735
2. Kissmeyer-Nielsen F., Olsen S., Petersen V.P., et al. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet 7465 (1966) 662
3. Williams G.M., Hume D.M., Hudson Jr. R.P., et al. 'Hyperacute' renal-homograft rejection in man. N Engl J Med 279 (1968) 611
4. Terasaki P.I. Humoral theory of transplantation. Am J Transplant 3 (2003) 665
5. Cai J., and Terasaki P. Human leukocyte antigen antibodies for monitoring transplant patients. Surg Today 35 (2005) 605
6. Amos D.B., Bashir H., Bogle W., et al. A simple microtoxicity test. Transplantation 7 (1970) 220
7. Bodmer J., Bodmer W.F., Payne R., et al. Leucocyte antigens in man: a comparison of lymphocytotoxic and agglutination assays for their detection. Nature 210 (1966) 28
8. Johnson A.H., Rossen R.D., and Butler W.T. Detection of alloantibodies using a sensitive antiglobulin microcytotoxicity test: identification of low levels of preformed antibodies in accelerated allograft rejection. Tissue Antigens 2 (1972) 215
9. Ting A., Hasegawa T., Ferrone S., et al. Presensitization detected by sensitive crossmatch tests. Transplant Proc 5 (1973) 813
10. Garovoy M.R., Rheinschmilt M.A., Bigos M., et al. Flow cytometry analysis: a high technology crossmatch technique facilitating transplantation. Transplant Proc 15 (1983) 1939
11. Fuller T., Phelan D., Gebel H., et al. The antigenic specificity of antibody reactive in the antiglobulin-augmented lymphocyte-toxicity test. Transplantation 34 (1982) 24
12. Zachary A.A., Klingman L., Thorne N., et al. Variations of the lymphocytotoxicity test. An evaluation of sensitivity and specificity. Transplantation 60 (1995) 498
13. Iwaki Y., Cook D.J., Terasaki P., et al. Flow cytometry crossmatching in human cadaver kidney transplantation. Transplant Proc 19 (1987) 764
14. Mahoney R.J., Ault K.A., Given S.R., et al. The flow cytometric crossmatch and early renal transplantation. Transplantation 49 (1990) 527
15. Ogura K., Terasaki P.I., Johnson C., et al. The significance of a positive flow cytometric crossmatch test in primary renal transplantation. Transplantation 56 (1993) 294
16. Christiaans M.H., Overhof R., ten Haaft, et al. No advantage of flow cytometry crossmatch over complement-dependent cytotoxicity in immunologically well-documented renal allograft recipients. Transplantation 15 (1996) 1341
17. Pelletier R.P., Orosz C.G., Adams P.W., et al. Clinical and economic impact of flow cytometry crossmatching in primary cadaveric kidney and simultaneous pancreas-kidney transplant recipients. Transplantation 63 (1997) 1639
18. Kerman R.H., Susskind B., Buyse I., et al. Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome. Transplantation 68 (1999) 1855
19. Le Bas-Bernardet S., Hourmant M., Valentin N., et al. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation. Transplantation 75 (2003) 477
20. Ettenger R.B., Jordan S.C., and Fine R.N. Cadaver renal transplant outcome in recipients with autolymphocytotoxic antibodies. Transplantation 35 (1983) 429
21. Vaidya S., Cooper T.Y., Avandsalehi J., et al. Improved flow cytometric detection of HLA alloantibodies using pronase. Transplantation 71 (2001) 422
22. Karuppan S.S., Ohlman S., and Moller E. The occurrence of cytotoxic and non-complement-fixing antibodies in the crossmatch serum of patients with early acute rejection episodes. Transplantation 54 (1992) 839
23. Braun W.E. Laboratory and clinical management of the highly sensitized organ transplant recipient. Hum Immunol 26 (1989) 245
24. Kao K.J., Scornik J.C., and Small S.J. Enzyme-linked immunoassay for anti-HLA antibodies-an alternative to panel studies by lymphocytotoxicity. Transplantation 55 (1993) 192
25. Pei R., Wang G., Tarsitani C., Rojo, et al. Simultaneous HLA class I and class II antibodies screening with flow cytometry. Hum Immunol 5 (1998) 313
26. Fulton R.J., McDade R.L., Smith P.L., et al. Advanced multiplexed analysis with the FlowMetrix™ system. Clin Chem 43 (1997) 1749
27. Bernabeu C., Finlay D., van de Rijn M., et al. Expression of the major histocompatibility antigens HLA-A2 and HLA-B7 by DNA-mediated gene transfer. J Immunol 131 (1983) 2032
28. Pei R., Lee J.-H., Shih N.-J., et al. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antibody specificities. Transplantation 75 (2003) 43
29. Gebel H.M., and Bray R.A. Sensitization and sensitivity: defining the unsensitized patient. Transplantation 69 (2000) 1370
30. Bray R.A., Nickerson P.W., Kerman R.H., and Gebel H.M. Evolution of HLA antibody detection: technology emulating biology. Immunol Res 29 (2004) 41
31. Nickerson P., Pochinco D., Karpinski M., et al. Class II donor specific antibodies are pathogenic in primary renal allografts. AJT 4 s8 (2004) 257
32. UNOS rationale for objective of equitable organ allocation. Richmond, VA.: United Network for Organ Sharing, 1994 (http://www.unos.org/resources/bioethics.asp?index=8).
33. Bray R.A., and Gebel H.M. PRA (predictive reactivity of alloantibody): a new approach for crossmatch prediction. AJT 5 s11 (2005) 489
34. Danovitch G.M. A kidney for all ages. Am J Transplant 6 (2006) 1267
35. Bray R.A., and Gebel H.M. Allele specific HLA alloantibodies. Implication for organ allocation. AJT 5 s11 (2005) 488
36. Gebel H.M., Bray R.A., and Nickerson P. Pre-transplant assessment of donor reactive antibody in renal transplantation: contraindication versus risk. Am J Transplant 3 (2003) 1488